Cancer Diagnostics Market

1
Cancer Diagnostics Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Global Cancer Diagnostics Market, By Product
(Consumables, Instruments), Type (Imaging
Testing, Biomarkers Testing, In Vitro Diagnostic
Testing, Biopsy, Others), Application (Lung
Cancer, Breast Cancer, Colorectal Cancer,
Melanoma Cancer, Prostate Cancer, Liver Cancer,
Others), End-User (Diagnostic Centres, Hospitals
and Clinics, Research Institutes, Others) and
region (North America, Europe, Asia-Pacific,
Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/cancer-dia
gnostics-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
Cancer is a leading cause of death worldwide,
affecting both developed and developing
countries. The prevalence of cancer has led to a
focus on developing effective screening and
treatment solutions to combat the disease.
Technological advancements in diagnostic tests
have played a significant role in accelerating
industry growth by enabling healthcare
professionals to detect cancer at earlier stages.
The development of effective screening and
treatment solutions is a collaborative effort
involving different healthcare professionals,
including doctors, researchers, and scientists.
Healthcare agencies and market players are
launching various programs promoting advanced
diagnostics to improve cancer detection and
treatment, which is expected to further
accelerate market growth. Purchase this
Report https//www.delvens.com/checkout/cancer-di
agnostics-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Cancer Diagnostics Market is segmented into
By product, By application, By end-use and
region. On the basis of product, the segment of
consumables stands as the principal contributor
to revenue, and it is anticipated to experience a
notable escalation throughout the envisaged time
frame. On the basis of application, the segment
pertaining to breast cancer, which is an
affliction that affects the mammary glands and
surrounding tissues, has emerged as the most
dominant stakeholder in the cancer diagnostics
market. This can be attributed to the marked
escalation in the incidence of breast cancer
across the globe, in conjunction with the surge
in the population of women belonging to the age
bracket of 50 to 74 years.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The market is also divided into various regions
such as North America, Europe, Asia-Pacific,
South America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/cancer-diagnostics-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Bristol-Myers Squibb Company
• Lilly
• Pfizer, Inc
• Genomic Health, Inc.
• bioMérieux SA
• Astellas Pharma Inc.
• Myriad Genetics, Inc.

• Abbott
• DiagnoCure Inc.
• Thermo Fisher Scientific
• Illumina, Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd
• Agilent Technologies, Inc.
• Quest Diagnostics Incorporated.
• Merck KGaA,
• Hologic, Inc.
• BD.
• GSK plc.
• Novartis AG

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In 2022, the company entered into a distribution
agreement for one of its products, HemeScreen,
with a major distribution partner in the United
States.HemeScreen is a diagnostic test that helps
in the detection of hematologic malignancies,
which are cancers that affect the blood, bone
marrow, and lymph nodes. The distribution
agreement is part of Precipio's strategy to
expand the distribution of HemeScreen.  In
November 2021, Siemens Healthineers introduced
Magnetom Free. Star, is a cost-effective
whole-body MRI scanner, designed to enable
significantly better access to magnetic resonance
imaging globally.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com